An accumulating number of high-quality preclinical studies have confirmed its efficacy for reducing hepatic lipogenesis, resulting in inactivation of liver X receptor α (LXRα) and inhibition of TNF-α, thereby preventing hepatic steatosis [20, 31]. This evidence concerns the gene NR1H3 and Hepatic steatosis.